PHOTO
Dubai: Auxein Medical, a leading global orthopaedic implant manufacturer and exporter, is conducting cadaver workshops and dry labs to enable surgeons to gain experience before stepping full-time in the field. Presenting their innovative range of orthopaedic implants at Arab Heath 2022, ongoing at the Dubai World Trade Centre, where entry is free for all, visitors can witness the future of orthopaedic possibilities at stand CC95.
Talking about different medical approaches and surgical techniques is essential for all medical practitioners for the proper advancement of the medical field. Mr. Rahul Luthra, International Sales Director, Auxein Medical, said, “With DAIS Academy, we are offering surgeons the chance to experiment with different medical approaches, techniques, and implants to find the best options for real-time surgeries. With live surgeries, cadaver workshops, dry labs, Auxein provides all these brilliant minds with the opportunity to experiment with different orthopaedic implants and witness their outcomes. As the quality of education and training improves, it results in better surgeons and better treatments, contributing to society's betterment. ”
Aiming to improve lives through innovative orthopaedic research and development, DAIS Academy is associated with universities and research institutes globally to enhance the field of research. Everyone in the medical field can carry out pre-clinical research, investigate medical devices, observe clinical outcomes of the devices, materials, and substances. DAIS Academy enables the ideation of better medical solutions by bringing different experts together under the same roof with a surgeon to surgeon training.
Prof. Dr. Sherif Khaled, Professor of Orthopaedic Surgery Cairo, said, “I have been associated with Auxein for more than ten years and have regularly imported their entire trauma line to Egypt for my patients. They offer similar quality to the biggest names and are focused on innovation and offering better solutions. I believe their decisions are beneficial to advancing the entire field of orthopaedics, especially with DAIS Academy and its webinars and surgeon on surgeon training. When we put bright minds together, new solutions are born, and leaps are made.”
The registration process is simple, and you can register for the webinars conducted by world-renowned surgeons at https://www.dais.academy . Surgeons can also reach out directly to the Auxein Medical team and view their process and a vast range of orthopaedic products at https://www.auxein.com
-Ends-
About Auxein Medical
Auxein Medical is a leading orthopaedic implant manufacturer and global exporter based in the USA, Mexico, India, and the United Arab Emirates. Reaching over 70+ countries, Auxein Medical has the prestigious Medical Device Single Audit Program Certification, including India’s first Medical Equipment Testing Lab. The brand places a special emphasis on observing regulatory norms and follows stringent quality checks in compliance with the requirements of US FDA. Adhering to the strictest standards in quality control, product design and development, prototyping, packaging, and sterilisation, all the products are certified by CE, in compliance with the European Medical Device Directive 93/42/EEC (as amended 2007/47/EC) and packaged as per EN 980 standards.
For Media Inquiries
Mrigaya Dham
Freelance Public Relations and Communications Manager
www.mrigayadham.com
© Press Release 2022
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
